PRA Health Sciences, Inc. Financing Cash Flow
PRA Health Sciences, Inc. reported Financing Cash Flow of $12.05 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-04-29
- PRA Health Sciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was $12.05M, a 70.75% decline year-over-year.
- PRA Health Sciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was $21.91M.
- PRA Health Sciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-09-30 was $4.91M.
- PRA Health Sciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-06-30 was $9.43M, a 68.80% decline year-over-year.
- PRA Health Sciences, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $77.43M.
- PRA Health Sciences, Inc. net cash provided by (used in) financing activities for fiscal 2019 was -$90.71M.
- PRA Health Sciences, Inc. net cash provided by (used in) financing activities for fiscal 2018 was -$319.51M, a 163.02% decline from fiscal 2017.
- PRA Health Sciences, Inc. net cash provided by (used in) financing activities for fiscal 2017 was $507.01M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-03-31 | $12.05M 10-Q · filed 2021-04-29 | $33.96M derived: sum of 2 quarters · filed 2021-04-29 | $38.86M derived: sum of 3 quarters · filed 2021-04-29 | $48.29M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | $21.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $26.82M derived: sum of 2 quarters · filed 2021-02-24 | $36.24M derived: sum of 3 quarters · filed 2021-02-24 | $77.43M 10-K · filed 2021-02-24 |
| 2020-09-30 | $4.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $14.33M derived: sum of 2 quarters · filed 2020-11-05 | $55.52M 10-Q · filed 2020-11-05 | -$66.23M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-06-30 | $9.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $50.61M 10-Q · filed 2020-08-07 | -$71.14M derived: sum of 3 quarters · filed 2021-04-29 | -$80.72M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-03-31 | $41.19M 10-Q · filed 2021-04-29 | -$80.56M derived: sum of 2 quarters · filed 2021-04-29 | -$90.15M derived: sum of 3 quarters · filed 2021-04-29 | -$59.94M derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | -$121.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$131.34M derived: sum of 2 quarters · filed 2021-02-24 | -$101.13M derived: sum of 3 quarters · filed 2021-02-24 | -$90.71M 10-K · filed 2021-02-24 |
| 2019-09-30 | -$9.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $20.62M derived: sum of 2 quarters · filed 2020-11-05 | $31.04M 10-Q · filed 2020-11-05 | -$66.85M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $30.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $40.63M 10-Q · filed 2020-08-07 | -$57.26M derived: sum of 3 quarters · filed 2021-02-24 | -$150.75M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $10.42M 10-Q · filed 2020-05-01 | -$87.47M derived: sum of 2 quarters · filed 2021-02-24 | -$180.96M derived: sum of 3 quarters · filed 2021-02-24 | -$224.48M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$97.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$191.38M derived: sum of 2 quarters · filed 2021-02-24 | -$234.90M derived: sum of 3 quarters · filed 2021-02-24 | -$319.51M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$93.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$137.00M derived: sum of 2 quarters · filed 2019-10-31 | -$221.62M 10-Q · filed 2019-10-31 | -$238.28M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | -$43.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$128.13M 10-Q · filed 2019-08-01 | -$144.80M derived: sum of 3 quarters · filed 2020-02-21 | $372.09M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | -$84.62M 10-Q · filed 2019-05-02 | -$101.28M derived: sum of 2 quarters · filed 2020-02-21 | $415.61M derived: sum of 3 quarters · filed 2020-02-21 | $429.16M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$16.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $500.22M derived: sum of 2 quarters · filed 2020-02-21 | $513.77M derived: sum of 3 quarters · filed 2020-02-21 | $507.01M 10-K · filed 2020-02-21 |
| 2017-09-30 | $516.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $530.43M derived: sum of 2 quarters · filed 2018-11-06 | $523.67M 10-Q · filed 2018-11-06 | $452.82M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $13.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $6.79M 10-Q · filed 2018-08-02 | -$64.06M derived: sum of 3 quarters · filed 2019-02-28 | -$63.79M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$6.76M 10-Q · filed 2018-04-26 | -$77.61M derived: sum of 2 quarters · filed 2019-02-28 | -$77.34M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2016-12-31 | -$70.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$70.58M derived: sum of 2 quarters · filed 2019-02-28 | -$101.59M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$30.75M 10-Q · filed 2017-10-26 | ||
| 2016-06-30 | -$31.02M 10-Q · filed 2017-08-08 |